Mir Hashim
2020
In 2020, Mir Hashim earned a total compensation of $630.3K as Chief Scientific Officer at Rani Therapeutics Holdings.
Compensation breakdown
| Non-Equity Incentive Plan | $160,000 |
|---|---|
| Option Awards | $144,750 |
| Salary | $325,532 |
| Total | $630,282 |
Hashim received $325.5K in salary, accounting for 52% of the total pay in 2020.
Hashim also received $160K in non-equity incentive plan and $144.8K in option awards.
Rankings
In 2020, Mir Hashim's compensation ranked 10,334th out of 13,090 executives tracked by ExecPay. In other words, Hashim earned more than 21.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,334 out of 13,090 | 21st |
Division Manufacturing | 4,428 out of 5,621 | 21st |
Major group Chemicals And Allied Products | 1,832 out of 2,254 | 19th |
Industry group Drugs | 1,604 out of 1,954 | 18th |
Industry Pharmaceutical Preparations | 1,184 out of 1,459 | 19th |
Source: SEC filing on April 13, 2022.
Hashim's colleagues
We found one more compensation record of an executive who worked with Mir Hashim at Rani Therapeutics Holdings in 2020.
2020
Svai Sanford
Rani Therapeutics Holdings